This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Self-Management » Self-Management

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Hemoglobin A1C Levels Strongly Linked to Subsequent Mortality in Diabetes

Posted: Friday, June 20, 2008

Hemoglobin A1C (A1C) levels are strongly associated with subsequent mortality in both men and women without a previous diabetes diagnosis, according to the results of the largest study to date of A1C levels and subsequent mortality risk, reported in the June issue of Diabetes Care. In those without known diabetes at baseline, a 1% increase in A1C level was associated with a 16% increase in mortality rate.

No Efficacy or Safety Sacrifice with Weekly Exenatide (Byetta LAR)

Posted: Friday, June 20, 2008

A long-acting version of the injectable diabetes drug exenatide (Byetta) showed efficacy advantages and safety comparable to the standard formulation given twice a day, researchers said.

HEART2D Study Shows No Cardiovascular Benefit by Targeting Postprandial Glucose Levels

Posted: Friday, June 20, 2008

A study examining the effects of hyperglycemia on type 2 diabetes patients after acute myocardial infarction (AMI), the Hyperglycemia and Its Effect After Acute Myocardial Infarction on Cardiovascular Outcomes in Patients With Type 2 Diabetes (HEART2D) study, found no cardiovascular benefits from tightly controlling postprandial variations in blood glucose.

Further Evidence Supports Vitamin-D-Deficiency Link to CHD

Posted: Friday, June 20, 2008

Further evidence that vitamin-D deficiency may increase the risk of heart disease has come from a new case-control study.

Treated Diabetes Associated With Increased Risk for Depression

Posted: Friday, June 20, 2008

Persons with treated type 2 diabetes are at increased risk for developing depression, while a more modest association was found between persons with depression and the risk of diabetes, according to a new study.

Investigational DPP-4 Inhibitor Effective as Add-On and Stand-Alone

Posted: Friday, June 20, 2008

Alogliptin, an investigational once-daily oral drug for type 2 diabetes, showed good efficacy and safety both as monotherapy and together with standard agents, researchers in five phase III trials stated at ADA Scientific Sessions.

Glycemic Control Markedly Improved with Duodenal-Jejunal Sleeve

Posted: Friday, June 20, 2008

For obese patients with diabetes, a Teflon-like sleeve placed inside the small intestine just beyond the stomach iimproves glycemic control quickly and markedly.

Diabetic Ulcer Gel Gets Black Box Warning

Posted: Friday, June 20, 2008

A black box warning has been added to the safety labeling for becaplermin gel (Regranex, Johnson & Johnson) to warn of the increased risk for cancer mortality in patients who use 3 or more tubes of the product, the US Food and Drug Administration (FDA) announced on Friday.

Diabetes Prevention Hopes Revived for Thiazolidinedione

Posted: Friday, June 20, 2008

Pioglitazone (Actos) may prevent or delay progression to diabetes for patients with pre-diabetes by 81%, researchers found.

Lifestyle, Not Genetics, Most Responsible for Insulin Resistance in Identical Twins

Posted: Thursday, June 19, 2008

A unique study performed on identical twins suggests that lifestyle choices, not genetics, plays the biggest role in the development of insulin resistance.